A 9252: Establishes a grant program to assist providers in purchasing opioid antagonists alongside automated external defibrillators; establishes criteria for such grant program.

  
  STATE OF NEW YORK ________________________________________________________________________ 9252 2025-2026 Regular Sessions  IN ASSEMBLY November 21, 2025 ___________ Introduced by M. of A. DAIS -- read once and referred to the Committee on Health AN ACT to amend the public health law and the state finance law, in relation to requiring opioid antagonists to be stored with all auto- mated external defibrillators in the state of New York and establish- ing a grant program to accomplish such goal The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1 Section 1. Legislative findings. The legislature finds that opioid 2 overdoses continue to be a leading cause of preventable death in the 3 State of New York. Immediate access to opioid antagonists, such as 4 naloxone nasal spray, can prevent fatalities and save lives. Automated 5 external defibrillators are strategically located in many public places 6 and emergency response settings. By mandating that automated external 7 defibrillator units also include opioid antagonists, New York state will 8 better equip bystanders and first responders to address both cardiac and 9 opioid-related emergencies, thus improving public safety and public 10 health outcomes. 11 § 2. Paragraph (c) of subdivision 1 of section 3000-b of the public 12 health law, as added by chapter 552 of the laws of 1998, is amended to 13 read as follows: 14 (c) "Public access defibrillation provider" means a person, firm, 15 organization or other entity possessing or operating an automated 16 external defibrillator pursuant to a collaborative agreement under this 17 section or public buildings, schools, transportation hubs, places of 18 public assembly, and other locations as designated by the commissioner. 19 § 3. Subdivision 4 of section 3000-b of the public health law is 20 renumbered subdivision 5 and a new subdivision 4 is added to read as 21 follows: 22 4. Opioid antagonists. (a) All public access defibrillation providers 23 shall cause the automated external defibrillator to also contain at 24 least one dose of an opioid antagonist, including but not limited to 25 naloxone nasal spray. EXPLANATION--Matter in italics (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD13975-01-5 
 A. 9252 2 1 (b) The commissioner shall promulgate rules and regulations establish- 2 ing minimum requirements for storage, labeling, replacement, training, 3 and maintenance of opioid antagonists co-located with the automated 4 external defibrillator units. 5 (c) All public access defibrillation providers shall also be responsi- 6 ble for the maintenance and timely replacement of opioid antagonists, 7 including expiration date tracking and proper storage. 8 (d) The department shall make available training resources for the 9 administration of opioid antagonists, including digital and on-site 10 formats, in conjunction with existing automated external defibrillator 11 training requirements. 12 § 4. The public health law is amended by adding a new section 3000-g 13 to read as follows: 14 § 3000-g. Public access defibrillation provider opioid antagonist 15 grant program. 1. There is hereby established a public access defibril- 16 lation provider opioid antagonist grant program to be administered by 17 the department. 18 2. The purpose of such program shall be to provide an incentive and 19 financial assistance to public access defibrillation providers who are 20 seeking to obtain opioid antagonists alongside automated external defi- 21 brillator units. 22 3. The department shall set criteria for eligibility for grant awards. 23 Those eligible to purchase opioid antagonists alongside automated 24 external defibrillator units, and who apply shall be eligible for grant 25 awards under such program. Grants awarded pursuant to this section shall 26 be used solely for the purpose of purchasing opioid antagonists and 27 shall prioritize for schools, libraries, and community centers located 28 in high-risk or underserved areas. 29 4. The public access defibrillation provider opioid antagonist program 30 shall be funded through the annual appropriation of the legislature or 31 any other funds received by the state for the purposes of this section, 32 including but not limited to funds administered in the public access 33 defibrillation provider opioid antagonist grant program fund pursuant to 34 section ninety-nine-tt of the state finance law. Grants shall only be 35 awarded based upon the availability of funds. 36 § 5. The state finance law is amended by adding a new section 99-tt to 37 read as follows: 38 § 99-tt. Public access defibrillation provider opioid antagonist grant 39 program fund. 1. There is hereby established in the joint custody of the 40 state comptroller and the commissioner of the department of health a 41 fund to be known as the "public access defibrillation provider opioid 42 antagonist grant program fund". 43 2. Such fund shall consist of all moneys collected therefor, or moneys 44 credited, appropriated or transferred thereto from any other fund or 45 source pursuant to law, or any other moneys made available for the 46 purposes of the fund. 47 3. Moneys of the fund, following appropriation by the legislature and 48 allocation by the commissioner of the department of health, shall be 49 available only for purposes of the public access defibrillation provider 50 opioid antagonist grant program, as set forth in section three thou- 51 sand-g of the public health law. 52 § 6. This act shall take effect January 1, 2027. Effective immediate- 53 ly, the addition, amendment and/or repeal of any rule or regulation 54 necessary for the implementation of this act on its effective date are 55 authorized to be made and completed on or before such effective date.